With Tuesday's bipartisan agreement to let senators vote on seven of President Obama's previously stalled nominations, the Senate proved that the art of compromise isn't dead in Washington, even if it might be severely wounded.
At a small park in Pyne Poynt on the north side of Camden, N.J., kids take practice cuts on the infield dirt and adjust their hats. A small but enthusiastic crowd shouts words of encouragement, but the cheering parents and playful bench-side scuffles only momentarily disguise the troubles in the city. Baggies, vials and hypodermic needles litter the same field where practice is being held.
"Each day, our kids walk past drug sets and open air drug use," says Bryan Morton, the North Camden Little League president.
In a blog series we're calling "Weekly Innovation," we'll explore an interesting idea, design or product that you may not have heard of yet. Last week we featuredthe sink-urinal. (Do you have an innovation to share?Use this quick form.)
Sometimes a drug hits cancer hard. Sometimes the cancer cells are unfazed. But it's often hard to know which outcome to expect.
A group of scientists at the National Cancer Institute has spent the last three years turning some mathematical algorithms loose on giant sets of data to better understand the relationship between cancerous cells and cancer drugs.